A new, world-class, functional genomics laboratory is set to further the UK’s global genomics leadership and accelerate the discovery of new medicines and diagnostics.
The functional genomics laboratory has been established through a partnership between:
- Medical Research Council (MRC)
- AstraZeneca
- Milner Therapeutics Institute (MTI), University of Cambridge
The laboratory will be a centre of excellence and national resource that combines the strengths and expertise of academia and industry.